Test of ActiGraft for draining skin wounds
Part of Injuries & trauma clinical trials.
This trial studies whether ActiGraft helps heal draining (exuding) skin wounds safely and effectively. If you join, the researchers may use your wound photos and health data to analyze results and publish findings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have a skin wound that is actively draining fluid
- Agree to share your health data, including wound photos, for analysis and publications
- Be able to read and understand English and/or Spanish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies ActiGraft to help heal an abdominal surgical wound that has reopened and needs a second closure. It may help the wound close more effectively when the wound is still early but has been open for more than 24 hours.
This study tests how well a pig-based covering dressing works on skin graft donor-site wounds (where skin is taken to make a graft). It may help support faster, safer healing after a split-thickness skin graft.
This study looks at how a wound dressing or treatment affects healing in surgical cuts that are closed with sutures or similar methods. You may be able to join if you’re having a skin surgery on the neck, trunk, or arms/legs with a long enough wound you can follow up on.
This trial tests a lab-grown skin product designed to help heal stubborn wounds that won't close on their own—including burns, diabetic foot ulcers, and pressure sores. The goal is to see if this engineered skin can speed up healing and reduce scarring.
This trial tests a new wound dressing called DERMASEAL for the area where a skin graft is taken (the donor site). It aims to see if DERMASEAL helps the donor site heal faster and with less pain than standard care.
This study checks whether a treatment using your own skin graft material is safe and feasible. It aims to see if using a small sample from your skin and making an “autologous” skin graft can be done safely and with good follow-through.
Hear when a new Cutaneous Wounds trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.